Skip to content

Clinical trials

Bipolar Disorder trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Country / region: China Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20071
20083
20091
20101
20125
20133
20152
20162
20174
20182
20191
20206
20215
20227
20234
202411
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status27
Completed24
Recruiting18
Not yet recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Mental Health Center14
First Affiliated Hospital of Zhejiang University12
Central South University8
Peking University6
AstraZeneca4
Eli Lilly and Company3
Guangzhou Psychiatric Hospital3
Tianjin Anding Hospital3
China Medical University, China2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder74
Major Depressive Disorder15
Schizophrenia12
Cognitive Dysfunction6
Mental Disorders5
Mania4
Anxiety Disorders3
Mood Disorders3
Autism Spectrum Disorder2
Depressive Disorder2

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.